The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.

An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.

Procter & Gamble and Unilever are among big packaged goods companies that would be exposed if U.S. President-elect Donald ...

Even if stocks don't pay every month, that doesn't mean you can't generate recurring cash flow throughout the year.

Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), The Procter & ...

(Reuters) -The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough ...

The consumer staples sector is comprised of companies that produce and sell essential goods such as food, beverages, ...

Shares of Salesforce and Procter & Gamble are posting positive gains Friday afternoon, propelling the Dow Jones Industrial Average into positive territory.

Procter & Gamble Health declared their Q1 results on November 4, 2024, showcasing a topline increase of 2.78% year-over-year, ...

Key Insights The projected fair value for Procter & Gamble is US$230 based on 2 Stage Free Cash Flow to Equity ...

Procter & Gamble Hygiene and Health Care’s Q2 2024 results showed flat revenue growth and just a 1% increase in PAT. At the ...

On Friday, Procter & Gamble Co (PG) stock saw a decline, ending the day at $165.1 which represents a decrease of $-0.08 or -0.05% from the prior close of $165.18. The stock opened at $165.31 and ...